PDF下载 ( 2119 KB)
Screening Chinese medicine components for inhibition of human hepatic stellate cell migration
-
摘要: 目的从6种已证实有抗肝纤维化作用的中药组分中,筛选出抑制肝星状细胞迁移的最佳者。方法培养人肝星状细胞株（LX-2）,用细胞迁移杯培养方法分别观察不同浓度梯度（10-4、10-5、10-6、10-7mol/L）的青蒿琥酯、灯盏花素、红景天苷、丹参酚酸B盐、粉防己碱、黄芪总甙对血小板衍生生长因子-BB（PDGF-BB）（10 ng/ml）诱导的LX-2迁移的抑制,从而筛选出各组分最佳作用浓度;随后比较各组分最佳浓度对LX-2迁移的抑制作用,而筛选出最佳组分。结果 6种中药组分均可抑制PDGF诱导的LX-2的迁移;但10-4mol/L丹参酚酸B盐、10-4mol/L黄芪总甙、10-4mol/L与10-5mol/L粉防己碱对LX-2形态有不同程度的影响;依照药物筛选原则,最终选出10-4mol/L青蒿琥酯、10-4mol/L灯盏花素、10-5mol/L红景天甙、10-5mol/L丹参酚酸B盐、10-6mol/L粉防己碱、10-6mol/L黄芪总甙为最佳浓度;将各组分最佳浓度进行统一比较证实,10-5mol/L红景天苷具有更好的抑制迁移作用。结论 10-5mol/L红景天苷抑制PDGF诱导的LX...Abstract: Objective To screen the best component from six of components of traditional Chinese medicine which were confirmed with the anti-fibrosis function.Methods A trans-well chamber system was used to observe the changes of the human hepatic stellated cell line (LX-2) migration.We select human HSC cell line (LX-2) which induced by platelet derived growth factor-BB (PDGF-BB) to study the effect of inhibition of migration.Cells were incubated with 10-4mol/L-10-7mol/L concentration of Artesunate, Breviscapine, Salidroside, Salvianolic acid B, Tetrandrine, Astragalosides, respectively.Results Six kinds of Chinese medicine components can inhibit the PDGF-induced migration of LX-2.10-4mol/L Salvianolic acid B, 10-4mol/L Astragalosides, 10-4mol/L Tetrandrine and10-5mol/L Tetrandrine have different affectiveness on cell morphology.Based on the principles of the selection, 10-4mol/L Artesunate, 10-4mol/L Breviscapine, 10-5mol/L Salidroside, 10-5mol/L Salvianolic acid B, 10-6mol/L Tetrandrine and 10-6mol/L Astragalosides can significantly inhibit LX-2 migration.Of six of them, 10-5mol/L Salvianolic has the best effectiveness (P<0.05) .Conclusion 10-5mol/L Salidroside is the most effective drugs that inhibit the migration of LX-2.
-
[1]L Xu, A Y Hui, E Albanis, et al.Human hepatic stellate cell lines, LX-1and LX-2:new tools for analysis of hepatic fi-brosis[J].Gut, 2005, 54:142-151. [2]肖柳英, 林培英, 张丹, 等.青蒿琥酯对小鼠肝癌及S180实体瘤的抑制作用[J].实用癌症杂志, 200l, 16 (3) :245-247. [3] 杨联萍, 马力, 张淑莲, 等.青蒿琥酯抗乙型肝炎病毒体外实验研究[J].实用临床医学, 2004, 18 (1) :1-2. [4]Romero MR, Efferth T, Serrano MA, et al.Effect of arte-misinin/artesunate as inhibitors of hepatitis Bvirus produc-tion in an“in vitro”replicative system[J].Antiviral Res, 2005, 68 (2) :75-83. [5]方步武, 来丽娜, 林雅军, 等.青蒿琥酯抗四氯化碳致大鼠肝纤维化的作用[J].中国药理学通报, 2005, 2 (6) :381-382. [6]刘金元, 杨冬娣.青蒿琥酯对肝纤维化小鼠肝细胞内CA2+分布的影响[J].新中医, 2010, 42 (1) :108-109. [7]吉明柱, 张永健.灯盏细辛治疗肝硬化的临床研究[J].交通医学, 2006, 20 (3) :267-269. [8]陈咏萍.灯盏花素对肝硬化微循环和纤维化指标的影响[J].黑龙江医药科学, 2006, 23 (5) :10. [9]杜钢军, 王梅, 林海红, 等.灯盏花素的肝纤维化保护作用[J].河南大学学报, 2009, 28 (3) :170-176. [10]王晓东, 刘永忠, 刘永刚.红景天苷体外抗肝纤维化的实验研究[J].时珍国医国药, 2004, 15 (3) :138-139. [11]王晓东, 刘永刚, 苏薇薇.红景天苷对小鼠实验性肝损伤的保护作用[J].中药材, 2004, 27 (3) :198-199. [12]周杨, 顾杰, 徐列明.丹参酚酸B盐抑制内皮素-1所致大鼠门静脉压力升高的药效及其作用机制[J].中西医结合学报, 2007, 5 (1) :61-64. [13]张杰, 张文炜, 徐列明.丹参酚酸B盐对内皮素诱导的人肝星状细胞收缩的抑制作用及机制研究[J].中国中西医结合杂志, 2009, 29 (1) :60-64. [14]孙自勤, 王要军, 权启镇, 等.汉防已甲素与秋水仙碱抗肝纤维化作用的比较[J].中国药理学通报, 1996, 12 (4) :345-347. [15]田字彬, 刘思良, 李定国, 等.防己甲素对血小板衍生生长因子促细胞增殖效应的阻断作用[J].中华医学杂志, 1997, 77 (1) :50-53. [16]李定国, 陆汉明, 陈颖伟.汉防己甲素抗肝纤维化研究进展[J].世界华人消化杂, 1999, 7 (2) :171-172. [17]柏长青, 宋颖芳, 王德堂, 等.黄芪、党参提取物抑制肺癌细胞诱导血管内皮细胞迁移的实验研究[J].武警医学, 2008, 6 (19) :505-506. [18]李淑萍, 许晓燕, 孙箴, 等.黄芪多糖和黄芪总甙调控LX-2细胞因子分泌[J].浙江大学学报, 2007, 36 (6) :545-547. -
本文二维码
计量
- 文章访问数: 3355
- HTML全文浏览量: 21
- PDF下载量: 726
- 被引次数: 0
下载:
